Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: J Adolesc Health. 2020 Aug 11;68(3):488–496. doi: 10.1016/j.jadohealth.2020.06.041

Table 1.

Scenario sets to evaluate the impact of pre-exposure prophylaxis (PrEP) use by adolescent sexual minority males using empirical adherence and retention parameters

Scenario seta Data source Study arm Adherence (% of PrEP users
adhering at each level)
Retention
1 EPIC: N = 121; MSM (ages 18–29); recruited through the CORE center, Chicago Il.; Primary outcomes: retention - attendance at 4, 12, 24, and 36 weeks; adherence - TFV-DP levels Standard care 57% – High (≥4 days; >719 fmol/punch plasma tenofovir)
14.3% – Moderate (2–3 days)b
14.3% – Low (<2 days)b
14.3% – None (BLQc)b
57% at 36 weeks
Intervention 72% – High (≥4 days; > 719 fmol/punch plasma tenofovir)
9.3% – Moderate (2–3 days)b
9.3% – Low (<2 days)b
9.3% – None (BLQc)b
80% at 36 weeks
2 ATN113: N = 78; ASMM (ages 15–17); recruited across the ATN cities; Primary outcomes: retentions - attendance at 4, 8, 12, 24, and 36 weeks; adherence - TFV-DP levels Standard care (last 36 weeks of ATN113) 27.5% – High (≥4 days; >719 fmol/punch plasma tenofovir)
9.3% – Moderate (2–3 days)
26.3% – Low (<2 days)
36.9% – None (BLQc)
50% at 48 weeks
Intervention (first 12 weeks of ATN113) 55.8% – High (≥4 days; >719 fmol/punch plasma Tenofovir)
16.9% – Moderate (2–3 days)
22.5% – Low (<2 days)
4.8% – None (BLQc)
3 EPIC and ATN113 Standard care (entire ATN113 study period) 41.6% – High (≥4 days; >719 fmol/punch plasma tenofovir)
13.1% – Moderate (2–3 days)
24.4% – Low (<2 days)
20.9% – None (BLQc)
50% at 48 weeks
Intervention (relative change in EPIC applied to standard care) 52.4% – High (≥4 days; >719 fmol/punch plasma tenofovir)
10.5% – Moderate (2–3 days)
20.0% – Low (<2 days)
17.1% – None (BLQc)
70% at 48 weeks

ASMM = adolescent sexual minority males; MSM = men who have sex with men.

a

Estimates of sexual mixing by age were derived from RADAR, a Chicago longitudinal cohort study of AMSM and young adult MSM.

b

EPIC only reported high adherence so the remaining fraction was distributed equally across the remaining categories.

c

BLQ = below the limit of quantitation.